Indivior Pharmaceuticals (INDV) Invested Capital (2021 - 2025)
Historic Invested Capital for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to -$189.0 million.
- Indivior Pharmaceuticals' Invested Capital changed N/A to -$189.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$189.0 million, marking a year-over-year change of. This contributed to the annual value of -$4.0 million for FY2024, which is 10714.29% down from last year.
- According to the latest figures from Q3 2025, Indivior Pharmaceuticals' Invested Capital is -$189.0 million.
- Over the past 5 years, Indivior Pharmaceuticals' Invested Capital peaked at $375.0 million during Q4 2022, and registered a low of -$267.0 million during Q1 2025.
- Moreover, its 5-year median value for Invested Capital was $10.0 million (2024), whereas its average is $19.4 million.
- Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 1867.09% in 2022, then tumbled by 277000.0% in 2025.
- Over the past 5 years, Indivior Pharmaceuticals' Invested Capital (Quarter) stood at $316.0 million in 2021, then rose by 18.67% to $375.0 million in 2022, then tumbled by 85.07% to $56.0 million in 2023, then tumbled by 107.14% to -$4.0 million in 2024, then plummeted by 4625.0% to -$189.0 million in 2025.
- Its last three reported values are -$189.0 million in Q3 2025, -$239.0 million for Q2 2025, and -$267.0 million during Q1 2025.